Clinical Trials Browser

Phase 1 × INDUSTRY × tucotuzumab celmoleukin × Clear all

NCT00132522 2013-10-25

EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide

Phase 1 Completed

GastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT00016237 2013-10-23

Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment

Phase 1 Completed

GenitourinaryThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Small Cell Lung Carcinoma